- Ashley McEvoy appointed President and CEO of Insulet Corporation (PODD, Financial).
- Ms. McEvoy brings extensive healthcare leadership experience from Johnson & Johnson.
- Insulet anticipates exceeding first quarter revenue guidance and plans to raise full-year guidance for 2025.
Insulet Corporation (PODD), renowned for its tubeless insulin pump technology, has announced the appointment of Ashley McEvoy as President and Chief Executive Officer, effective immediately. Ms. McEvoy succeeds Jim Hollingshead, who will transition to a consulting role to ensure a smooth handover. This leadership change arrives as Insulet aims to strengthen its market position and drive future growth.
Ms. McEvoy, previously Executive Vice President and Worldwide Chairman of Johnson & Johnson’s MedTech division, is recognized for her strategic vision and ability to drive growth. Her experience includes significant contributions to diabetes care and advancing technology-driven healthcare solutions. The Insulet Board expressed confidence that her leadership will enhance the company's innovation and global reach.
In addition to the leadership transition, Insulet forecasts surpassing its first-quarter revenue estimates and plans to adjust its full-year guidance for 2025, reflecting strong growth expectations. The company's next earnings call, scheduled for May 8, 2025, will provide further financial details. Meanwhile, Insulet's planned Investor Day has been postponed and will be rescheduled.
Insulet's flagship Omnipod 5 Automated Insulin Delivery System continues to maintain market leadership in both the U.S. and Europe, with particular advancements in type 1 and type 2 diabetes management. The company remains committed to expanding its impact on diabetes care through innovation and strategic market expansion.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
